REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/03/2025
Voltar para busca
Dado oficial do USPTO
PROGENTEC DIAGNOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PROGENTEC DIAGNOSTICS
ST13
US500000088258685Classe
35, 38, 42
Pedido
88258685
Registro
6005176
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
10/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 38, 42
Data de depósito
11/01/2019
Data de registro
10/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2020
Última transação
10/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
11/01/2019
Primeiro uso no comércio
11/01/2019
Código do desenho
4
Tipo de titular
03
Localização do titular
Oklahoma City, OK
Examinador
WELLS, KELLEY
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Progentec Diagnostics, Inc.
Representantes
EDWIN FLORES CHALKER FLORES, LLP
Classificação técnica
Classes Nice
Classe 35Classe 38Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trialspatient enrollment tracking and monitoringpharmaceutical and medicine tracking; business consulting and management in the field of clinical trialscompilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trialsclinical data management; marketing consultingdesigning and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticalsbiologicsdiagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocolstake part in clinical studies and recruit patients to take part in clinical studies; promoting public awareness of the need for improved prevention and treatment of illnessesfor improved health care quality and efficiency; public advocacy to promote awareness of the need for assuring patients safe access to affordable medicine; promoting technical and scientific investigationresearchexperimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticalsdiagnostic toolsbiomarkers and medical devices; and public advocacy to promote awareness of scientificresearch and medical advances
Classe 38
Providing access to a computer database; providing on-line forums for transmission of messages among computer and mobile device users concerning patientdoctor and caregiver information in order to generatemanage and share medical information; and provision of access to databases
Classe 42
Medical and scientific research and development in the field of medicinethe preventiontreatmentmanagement of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical toolspreparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemicalbiochemicalbiological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating theretoscientific analysis in the fields of pharmaceutical and medical device /diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products/services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; and working on and evaluation of biomarkers and diagnostic products; and providing an online network service that enables users to share data in the field of healthcare; non-downloadable computer software provided via the Internet as an Application Service Provider ASP-hosted solution for the collectioneditingorganizingmodifyingbook markingtransmissionstorage and sharing of data and information
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2019
PUBO
PUBLISHED FOR OPPOSITION
24/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
18/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
18/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2019
GNRT
NON-FINAL ACTION E-MAILED
07/05/2019
CNRT
NON-FINAL ACTION WRITTEN
07/05/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
25/04/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
23/04/2019
ALIE
ASSIGNED TO LIE
03/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
13/03/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/03/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
13/03/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/03/2019
DOCK
ASSIGNED TO EXAMINER
05/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2019
NWAP
NEW APPLICATION ENTERED
15/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PROGENTEC DIAGNOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.